Go Pro

Healthcare of Ontario Pension Plan Trust Fund Has $62.17 Million Stock Holdings in Kenvue Inc. $KVUE

Kenvue logo with Consumer Staples background
Image from MarketBeat Media, LLC.

Key Points

  • Healthcare of Ontario Pension Plan Trust Fund increased its Kenvue stake by 187.4% in the first quarter, ending with 3.61 million shares valued at about $62.17 million.
  • Kenvue’s latest quarterly results beat expectations, with EPS of $0.32 versus $0.27 expected and revenue of $3.91 billion, up 4.5% year over year.
  • Wall Street remains mostly cautious on KVUE: analysts’ consensus rating is Hold with an average target price of $19.58, while the stock recently traded around $19.25 and offers a 4.3% dividend yield.
  • MarketBeat previews the top five stocks to own by August 1st.

Healthcare of Ontario Pension Plan Trust Fund lifted its holdings in shares of Kenvue Inc. (NYSE:KVUE - Free Report) by 187.4% during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 3,606,388 shares of the company's stock after purchasing an additional 2,351,653 shares during the period. Healthcare of Ontario Pension Plan Trust Fund owned 0.19% of Kenvue worth $62,174,000 at the end of the most recent reporting period.

Other large investors have also added to or reduced their stakes in the company. Physician Wealth Advisors Inc. boosted its holdings in shares of Kenvue by 67.5% during the 4th quarter. Physician Wealth Advisors Inc. now owns 1,533 shares of the company's stock worth $26,000 after buying an additional 618 shares in the last quarter. Elyxium Wealth LLC acquired a new stake in shares of Kenvue during the 4th quarter worth approximately $26,000. MV Capital Management Inc. bought a new stake in shares of Kenvue in the 4th quarter valued at $28,000. Reflection Asset Management bought a new stake in shares of Kenvue in the 4th quarter valued at $32,000. Finally, SBI Securities Co. Ltd. lifted its position in shares of Kenvue by 82.4% during the 4th quarter. SBI Securities Co. Ltd. now owns 2,273 shares of the company's stock valued at $39,000 after acquiring an additional 1,027 shares during the period. Institutional investors and hedge funds own 97.64% of the company's stock.

Wall Street Analyst Weigh In

KVUE has been the topic of several research analyst reports. Citigroup cut their target price on shares of Kenvue from $20.00 to $19.00 and set a "neutral" rating on the stock in a research note on Wednesday, April 15th. Weiss Ratings raised shares of Kenvue from a "hold (c-)" rating to a "hold (c)" rating in a research note on Monday, June 15th. Barclays upped their price objective on shares of Kenvue from $18.00 to $19.00 and gave the company an "equal weight" rating in a report on Tuesday. Wall Street Zen raised shares of Kenvue to a "buy" rating in a research report on Sunday, July 12th. Finally, UBS Group raised their target price on Kenvue from $18.00 to $20.00 and gave the company a "neutral" rating in a research note on Thursday, July 16th. Three analysts have rated the stock with a Buy rating and thirteen have assigned a Hold rating to the company. According to data from MarketBeat, Kenvue has a consensus rating of "Hold" and a consensus target price of $19.58.

Check Out Our Latest Analysis on KVUE

Kenvue Price Performance

Shares of KVUE opened at $19.25 on Friday. Kenvue Inc. has a 12-month low of $14.02 and a 12-month high of $22.87. The business's fifty day moving average is $18.38 and its 200 day moving average is $17.92. The company has a quick ratio of 0.70, a current ratio of 0.98 and a debt-to-equity ratio of 0.67. The stock has a market cap of $36.97 billion, a P/E ratio of 22.65, a P/E/G ratio of 1.46 and a beta of 0.47.

Kenvue (NYSE:KVUE - Get Free Report) last posted its quarterly earnings results on Thursday, May 7th. The company reported $0.32 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.27 by $0.05. The business had revenue of $3.91 billion during the quarter, compared to the consensus estimate of $3.84 billion. Kenvue had a net margin of 10.61% and a return on equity of 20.81%. Kenvue's revenue was up 4.5% compared to the same quarter last year. During the same quarter last year, the firm posted $0.24 EPS. Sell-side analysts anticipate that Kenvue Inc. will post 1.16 earnings per share for the current fiscal year.

Kenvue Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, May 27th. Stockholders of record on Wednesday, May 13th were issued a dividend of $0.2075 per share. This represents a $0.83 dividend on an annualized basis and a dividend yield of 4.3%. The ex-dividend date was Wednesday, May 13th. Kenvue's dividend payout ratio (DPR) is currently 97.65%.

Insider Activity

In other news, General Counsel Matthew Orlando sold 38,491 shares of the business's stock in a transaction dated Friday, May 8th. The shares were sold at an average price of $17.66, for a total transaction of $679,751.06. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. 1.59% of the stock is owned by corporate insiders.

Kenvue Profile

(Free Report)

Kenvue is a consumer health company that was established as a standalone, publicly traded business after separating from Johnson & Johnson. Listed on the New York Stock Exchange under the symbol KVUE, Kenvue focuses on the development, manufacture, marketing and distribution of consumer health and personal care products across a range of categories including skin and beauty care, baby care, oral care, wound care and over‑the‑counter medicines.

The company owns and markets a portfolio of widely recognized consumer brands, including names familiar to global shoppers across retail and pharmacy channels.

See Also

Want to see what other hedge funds are holding KVUE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Kenvue Inc. (NYSE:KVUE - Free Report).

Institutional Ownership by Quarter for Kenvue (NYSE:KVUE)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Kenvue Right Now?

Before you consider Kenvue, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Kenvue wasn't on the list.

While Kenvue currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Click the link to see our list of which EV stocks show the most long-term potential.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines